Algert Global LLC reduced its stake in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 46.8% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,146 shares of the business services provider's stock after selling 5,411 shares during the period. Algert Global LLC's holdings in Exponent were worth $498,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in the business. Whipplewood Advisors LLC increased its holdings in Exponent by 5,333.3% in the first quarter. Whipplewood Advisors LLC now owns 326 shares of the business services provider's stock valued at $26,000 after buying an additional 320 shares in the last quarter. UMB Bank n.a. increased its holdings in Exponent by 859.1% in the first quarter. UMB Bank n.a. now owns 633 shares of the business services provider's stock valued at $51,000 after buying an additional 567 shares in the last quarter. Bessemer Group Inc. increased its holdings in Exponent by 103.3% in the first quarter. Bessemer Group Inc. now owns 681 shares of the business services provider's stock valued at $55,000 after buying an additional 346 shares in the last quarter. Johnson Financial Group Inc. purchased a new position in Exponent in the fourth quarter valued at $59,000. Finally, Caitong International Asset Management Co. Ltd increased its holdings in Exponent by 8,092.9% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,147 shares of the business services provider's stock valued at $93,000 after buying an additional 1,133 shares in the last quarter. Hedge funds and other institutional investors own 92.37% of the company's stock.
Exponent Trading Down 1.2%
EXPO traded down $0.90 on Friday, reaching $71.33. The stock had a trading volume of 144,088 shares, compared to its average volume of 325,014. Exponent, Inc. has a 12-month low of $63.81 and a 12-month high of $115.75. The business's 50-day moving average price is $72.59 and its two-hundred day moving average price is $77.55. The company has a market cap of $3.60 billion, a P/E ratio of 35.67 and a beta of 0.89.
Exponent (NASDAQ:EXPO - Get Free Report) last released its earnings results on Thursday, July 31st. The business services provider reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. The business had revenue of $132.87 million during the quarter, compared to analysts' expectations of $130.82 million. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The company's quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.57 earnings per share. As a group, analysts predict that Exponent, Inc. will post 1.98 earnings per share for the current year.
Exponent Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, September 19th. Stockholders of record on Friday, September 5th will be paid a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, September 5th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.7%. Exponent's payout ratio is currently 60.00%.
Insider Transactions at Exponent
In related news, CEO Catherine Corrigan sold 4,896 shares of the business's stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $71.09, for a total transaction of $348,056.64. Following the transaction, the chief executive officer directly owned 81,342 shares in the company, valued at approximately $5,782,602.78. The trade was a 5.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, VP Joseph Sala sold 1,595 shares of the business's stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $70.64, for a total transaction of $112,670.80. The disclosure for this sale can be found here. Insiders own 1.60% of the company's stock.
Exponent Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Recommended Stories

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.